+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Overactive Bowel Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Overactive Bowel Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Radiotherapy Induced Oral Mucositis - Pipeline Insight, 2025 - Product Thumbnail Image

Radiotherapy Induced Oral Mucositis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Zollinger Ellison Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Zollinger Ellison Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Short Bowel Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Short Bowel Syndrome - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 66 Pages
  • Global
From
From
From
Gastrointestinal OTC Drugs Market 2025-2033 - Product Thumbnail Image

Gastrointestinal OTC Drugs Market 2025-2033

  • Report
  • March 2025
  • 147 Pages
  • Global
From
From
From
From
Simethicone - Global Strategic Business Report - Product Thumbnail Image

Simethicone - Global Strategic Business Report

  • Report
  • September 2025
  • 282 Pages
  • Global
From
From
Gastric Motility Disorder Drugs - Global Strategic Business Report - Product Thumbnail Image

Gastric Motility Disorder Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 371 Pages
  • Global
From
Gastroparesis Treatment - Global Strategic Business Report - Product Thumbnail Image

Gastroparesis Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 463 Pages
  • Global
From
Rabeprazole Sodium - Global Strategic Business Report - Product Thumbnail Image

Rabeprazole Sodium - Global Strategic Business Report

  • Report
  • September 2025
  • 364 Pages
  • Global
From
Psyllium Husk Powder - Global Strategic Business Report - Product Thumbnail Image

Psyllium Husk Powder - Global Strategic Business Report

  • Report
  • September 2025
  • 477 Pages
  • Global
From
Appendicitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Appendicitis Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 386 Pages
  • Global
From
Camylofin - Global Strategic Business Report - Product Thumbnail Image

Camylofin - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
Ceftriaxone - Global Strategic Business Report - Product Thumbnail Image

Ceftriaxone - Global Strategic Business Report

  • Report
  • September 2025
  • 281 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more